share_log

Organogenesis Hldgs Analyst Ratings

オルガノジェネシスはアナリストの評価をホールディングスしています

Benzinga ·  2023/11/14 09:30
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/14/2023 48.94% Morgan Stanley $3 → $3.5 Maintains Equal-Weight
08/11/2023 27.66% Morgan Stanley $5 → $3 Maintains Equal-Weight
08/10/2023 70.21% BTIG $10 → $4 Maintains Buy
06/15/2023 112.77% Morgan Stanley → $5 Initiates Coverage On → Equal-Weight
05/24/2023 325.53% BTIG → $10 Upgrades Neutral → Buy
11/10/2022 BTIG Downgrades Buy → Neutral
11/10/2021 751.06% SVB Leerink $26 → $20 Maintains Outperform
08/10/2021 963.83% Credit Suisse $24 → $25 Maintains Outperform
05/11/2021 1006.38% SVB Leerink $27 → $26 Maintains Outperform
03/17/2021 836.17% SVB Leerink $19 → $22 Maintains Outperform
01/20/2021 453.19% SVB Leerink $10 → $13 Maintains Outperform
01/07/2021 282.98% Credit Suisse $8 → $9 Maintains Outperform
11/18/2020 325.53% SVB Leerink $9 → $10 Maintains Outperform
11/10/2020 240.43% Credit Suisse $7 → $8 Maintains Outperform
08/11/2020 282.98% SVB Leerink $7 → $9 Maintains Outperform
05/12/2020 197.87% SVB Leerink $8 → $7 Maintains Outperform
04/09/2020 240.43% BTIG $9 → $8 Maintains Buy
01/10/2020 282.98% SVB Leerink → $9 Initiates Coverage On → Outperform
08/26/2019 Credit Suisse Reinstates → Outperform
05/02/2019 282.98% Credit Suisse → $9 Initiates Coverage On → Outperform
04/17/2019 368.09% Oppenheimer → $11 Initiates Coverage On → Outperform
04/12/2019 BTIG Initiates Coverage On → Buy
04/11/2019 368.09% SunTrust Robinson Humphrey → $11 Initiates Coverage On → Buy

What is the target price for Organogenesis Hldgs (ORGO)?

The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on November 14, 2023. The analyst firm set a price target for $3.50 expecting ORGO to rise to within 12 months (a possible 48.94% upside). 5 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Organogenesis Hldgs (ORGO)?

The latest analyst rating for Organogenesis Hldgs (NASDAQ: ORGO) was provided by Morgan Stanley, and Organogenesis Hldgs maintained their equal-weight rating.

When is the next analyst rating going to be posted or updated for Organogenesis Hldgs (ORGO)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Organogenesis Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Organogenesis Hldgs was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.

Is the Analyst Rating Organogenesis Hldgs (ORGO) correct?

While ratings are subjective and will change, the latest Organogenesis Hldgs (ORGO) rating was a maintained with a price target of $3.00 to $3.50. The current price Organogenesis Hldgs (ORGO) is trading at is $2.35, which is out of the analyst's predicted range.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする